U.S. Department of Defense – Inovio, COVID-19 Vaccine Delivery Device, Other Transaction Prototype Agreement Post author:GHIAA Admin Post published:September 1, 2023 Post category: Continue ReadingU.S. Department of Defense – Inovio, COVID-19 Vaccine Delivery Device, Other Transaction Prototype Agreement
NIH – UniQure, AAV5 Gene Therapies Exclusive and Non-Exclusive License Agreement Post author:GHIAA Admin Post published:August 31, 2023 Post category: Continue ReadingNIH – UniQure, AAV5 Gene Therapies Exclusive and Non-Exclusive License Agreement
PHS – Biosyn, HIV Prophylactic Exclusive License Agreement Post author:GHIAA Admin Post published:August 25, 2023 Post category: Continue ReadingPHS – Biosyn, HIV Prophylactic Exclusive License Agreement
NIH – Fluidigm, COVID-19 Diagnostic Development Agreement Post author:GHIAA Admin Post published:August 24, 2023 Post category: Continue ReadingNIH – Fluidigm, COVID-19 Diagnostic Development Agreement
DNDi Template Development Collaboration and License Agreement Post author:GHIAA Admin Post published:April 18, 2023 Post category: Continue ReadingDNDi Template Development Collaboration and License Agreement
DNDi Template Research Collaboration and License Agreement Post author:GHIAA Admin Post published:April 14, 2023 Post category: Continue ReadingDNDi Template Research Collaboration and License Agreement
Yale University – BIND Biosciences, Cancer Therapeutic, Exclusive License Agreement Post author:GHIAA Admin Post published:March 3, 2023 Post category: Continue ReadingYale University – BIND Biosciences, Cancer Therapeutic, Exclusive License Agreement
CEPI – Valneva, Chikungunya Vaccine Funding Agreement Post author:GHIAA Admin Post published:January 11, 2023 Post category: Continue ReadingCEPI – Valneva, Chikungunya Vaccine Funding Agreement
CEPI – VBI, COVID-19 Vaccine Development Funding Agreement Post author:GHIAA Admin Post published:December 12, 2022 Post category: Continue ReadingCEPI – VBI, COVID-19 Vaccine Development Funding Agreement